Refractory Epilepsy in a Child with a Cortical Lesion
An 8-year-old girl has focal seizures that are refractory to two appropriately chosen and dosed antiepileptic drugs. Seizures occur several times per week, and she has developed declining school performance and behavioral difficulties. MRI shows a well-defined lesion in the left frontal lobe with features suggestive of a focal cortical dysplasia or a low-grade tumor; there is no mass effect. Video-EEG telemetry captures a seizure with a left frontal onset. Her parents are anxious about surgery and ask about 'just trying another medication'.
1. How do you evaluate candidacy for epilepsy surgery, and why is early referral important in children?
Read the worked answer
Evaluation involves a structured presurgical workup:
- Confirm drug-resistant epilepsy - failure of two appropriately chosen and dosed antiepileptic drugs.
- Characterize the seizure semiology and EEG - video-EEG telemetry to localize onset.
- Structural imaging - high-resolution MRI (epilepsy protocol) to identify the lesion; the lesion may be the epileptogenic zone or adjacent to it.
- Functional imaging - FDG-PET, magnetoencephalography, or ictal SPECT as adjuncts, especially if MRI and EEG are discordant.
- Neuropsychological assessment - baseline cognition and to identify risks.
- Invasive monitoring - intracranial EEG if noninvasive data are discordant or the lesion is near eloquent cortex.
Early referral is important because uncontrolled seizures in children impair cognitive development, school performance, and behavior, and because early surgery improves developmental outcomes and reduces the risk of injury and sudden unexpected death in epilepsy (SUDEP). The judgement is to avoid prolonged medication trials when the criteria for drug resistance are met.
2. How do you counsel the family about the risks and benefits of surgery versus continued medical therapy?
Read the worked answer
Benefits of surgery:
- Potential for seizure freedom or significant reduction, with improved cognition, behavior, and quality of life.
- Reduced medication burden and SUDEP risk.
Risks:
- Neurological deficit if the lesion is near eloquent cortex (motor, language). Functional mapping and, if needed, awake or asleep motor mapping reduce this risk.
- Incomplete seizure control; the need for continued medication.
- Surgical complications (infection, hemorrhage, edema).
Continued medical therapy:
- Additional medications have limited additional efficacy after drug resistance and carry side effects (cognitive, behavioral, metabolic).
- Ongoing seizure risk and developmental impact.
Counsel that the decision is individualized, that the lesion and EEG concordance favor a good outcome, and that a multidisciplinary team (epileptologist, neurosurgeon, neuropsychologist, neuroradiologist) should be involved. Document the shared decision-making discussion.
3. What is the role of the lesion type (focal cortical dysplasia versus low-grade tumor) in surgical planning and prognosis?
Read the worked answer
- Focal cortical dysplasia (FCD) - often extends beyond the visible MRI abnormality; complete resection of the dysplastic zone (including the transmantle sign or subtle cortical thickening) is the strongest predictor of seizure freedom. Invasive monitoring may be needed to define the extent.
- Low-grade tumor (e.g., ganglioglioma, DNET, pilocytic astrocytoma) - seizure freedom is high after gross total resection, and the oncological prognosis is generally favorable. The goal is complete resection with preservation of function.
In both cases, the epileptogenic zone may extend into adjacent cortex, so the surgical plan should combine structural imaging, EEG, and functional mapping. Prognosis for seizure freedom is good when the lesion is completely resected and concordant with EEG; residual tissue increases the risk of recurrence. Follow-up with imaging and EEG is required.